Seagen Inc (SGEN)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | David R. Epstein |
| Employees: | 3,260 |
| Web site: | seagen.com |
|
21823 30TH DRIVE SE, SUITE, BOTHELL, WA, 98021
4255274000
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate, PADCEV, and TUKYSA. It also develops TIVDAK for metastatic cervical cancer and other solid tumors.
Please log in first to see chart